scispace - formally typeset
J

John Attia

Researcher at University of Newcastle

Publications -  796
Citations -  39731

John Attia is an academic researcher from University of Newcastle. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 91, co-authored 727 publications receiving 32950 citations. Previous affiliations of John Attia include John Hunter Hospital & McMaster University.

Papers
More filters
Journal ArticleDOI

Risk factors and clinical presentation of craniocervical arterial dissection : a prospective study

TL;DR: Describing and comparative data on intrinsic and extrinsic risk factors for craniocervical arterial dissection and outline the typical clinical presentation are provided, including the nature of early presenting features which might assist practitioners to identify those patients for whom vigorous manual therapy of the neck is inappropriate and alert them to those for whom immediate urgent medical care should be sought.
Journal ArticleDOI

Exposure to house painting and the use of floor treatments and the risk of childhood acute lymphoblastic leukemia

TL;DR: Overall, there was little evidence of an increased risk with painting inside the house in the year before theregnancy, during the pregnancy, or after the child's birth; however, the risk appeared to be increased in certain circumstances.
Journal ArticleDOI

The influence of initial stroke severity on mortality, overall functional outcome and in-hospital placement at 90 days following acute ischemic stroke: A tertiary hospital stroke register study.

TL;DR: In this acute stroke cohort, initial stroke severity had a major impact on the likelihood of death following an AIS and appears to be the dominant influence on the overall stroke outcome and in-hospital placement.
Journal ArticleDOI

Pegylated interferon-α2β in combination with ribavirin does not aggravate thyroid dysfunction in comparison to regular interferon-α2β in a hepatitis C population: Meta-analysis

TL;DR: The purpose of this study was to assess the risk of developing thyroid disease with pegylated IFN (pIFN) versus regularIFN (r IFN) therapy (in combination with RBV), and pooled the results with previous studies in a meta‐analysis.